Nucleus Genomics vs OpenEvidence
Which Healthcare AI tool is better in 2026?
Nucleus Genomics
AI-powered whole-genome DNA analysis for proactive health and family planning
OpenEvidence
AI medical assistant for clinicians
Side-by-side
OpenEvidence is the more established option (raised $735M); pricing is comparable on both sides.
| Metric | Nucleus Genomics | OpenEvidence |
|---|---|---|
| Taglinei | AI-powered whole-genome DNA analysis for proactive health and family planning | AI medical assistant for clinicians |
| Foundedi | 2021🏆 | 2022 |
| HQi | New York, US | San Francisco, US |
| Employeesi | 11-50 | 50-200🏆 |
| Neuron scorei | 51 | 63🏆 |
| Total fundingi | $32M | $735M🏆 |
| Latest roundi | Series A · Jan 2025 | Series D · Jan 2026 |
| Valuationi | — | $12B🏆 |
| Cheapest paid plani | Pricing not disclosed | — |
| Free plani | ✗ | ✗ |
| Free triali | ✓ | ✗ |
| Top tier pricei | Pricing not disclosed | Enterprise · Contact sales |
| Pricing summaryi | Free trial | 1 published plans |
| Categoriesi |
Capability matrix
Developer-facing capabilities and access signals for Nucleus Genomics and OpenEvidence.
| Capability | Nucleus Genomics | OpenEvidence |
|---|---|---|
| MCP support | ✗ | ✗ |
| Public API | ✗ | ✓ |
| Webhooks | ✗ | ✗ |
| OAuth 2.0 | ✗ | ✗ |
| SDK languages | — | 2 (TypeScript, Python) |
| Free plan | ✗ | ✗ |
| Free trial | ✓ | ✗ |
| Verified | ✗ | ✓ |
| Active deal | ✗ | ✗ |
🟢 Strengths of Nucleus Genomics
- Offers a free trial
- More mature (2021)
🔵 Strengths of OpenEvidence
- Has raised more capital ($735M vs $32M)
- Higher Neuron score (63 vs 51)
- Newer company (2022)
- Verified profile
Which should you choose?
Choose OpenEvidence if price matters most — it starts at Freemium, which is friendlier for teams watching burn. Both AI Healthcare tools ship core features, so the cost delta often decides it for small teams and solo operators.
Choose OpenEvidence if you want the most established option — it has raised $735M, suggesting more runway for enterprise features, support, and long-term roadmap. For mission-critical workflows or larger teams, that stability often outweighs a lower monthly price.
Frequently asked questions
Nucleus Genomics vs OpenEvidence — which is better?
It depends on your priority. Nucleus Genomics is the leaner option; OpenEvidence has broader feature depth. See the side-by-side table above.
Is Nucleus Genomics cheaper than OpenEvidence?
No — OpenEvidence's cheapest paid plan is Freemium, while Nucleus Genomics's is Free trial.
Do Nucleus Genomics and OpenEvidence offer free plans?
Nucleus Genomics: Free trial only. OpenEvidence: Paid only.
Explore more AI Healthcare tools
Contextual paths to related AI startups, deals and rankings.